FAIR DATA SHARING & DATA CARING IN THE DIGITALIZED ERA: ASPIRATIONS, REALITIES & LEGAL CLASHES IN THE HEALTH & LIFE SCIENCES: Abstract of presentation at Stanford Law School

Timo Minssen

Abstract

The huge prospects of Big Data, advanced machine learning and AI, as well as the shift to more “personalized”, “open” and “transparent” innovation models stress the importance of an effective governance, regulation and stimulation of shareable data-applications in the health & life sciences. Yet, cutting edge medical innovation requires more than freely available big data and machine-generated data. Pushing the boundaries of biomedical research also demands smart data and high quality data that are created and nourished through human intervention and considerable investments in an highly competitive environment. Intellectual Property Rights (IPRs) and related rights come into play when data producers protect their investment in such data. While the need of recalibrating IPRs to fully support “big and smart data” advances is being intensely debated, there seems to be much confusion about the availability of IPRs and their legal effects. This presentation provides a very brief overview on selected areas that demonstrate emerging tensions at the interface of Big Data, Standardization, IPRs and Competition/Antitrust Law.

Originalsprog	Engelsk
Publikationsdato	mar. 2018
Status	Udgivet - mar. 2018
Begivenhed	BIOLAWLAPALOOZA 2018 - Stanford Law School, Palo Alto, USA Varighed: 22 mar. 2018 → 23 mar. 2018 https://law.stanford.edu/center-for-law-and-the-biosciences/

Konference

Konference	BIOLAWLAPALOOZA 2018
Lokation	Stanford Law School
Land/Område	USA
By	Palo Alto
Periode	22/03/2018 → 23/03/2018
Internetadresse	https://law.stanford.edu/center-for-law-and-the-biosciences/

FN’s Verdensmål

Dette resultat bidrager til følgende verdensmål

Adgang til dokumentet

BioLawLapalooza Abstracts 3.21.18

Citationsformater

@conference{5e73b38ae22544fdb8458b4b0f21725f,

title = "FAIR DATA SHARING & DATA CARING IN THE DIGITALIZED ERA: ASPIRATIONS, REALITIES & LEGAL CLASHES IN THE HEALTH & LIFE SCIENCES: Abstract of presentation at Stanford Law School",

abstract = "The huge prospects of Big Data, advanced machine learning and AI, as well as the shift to more “personalized”, “open” and “transparent” innovation models stress the importance of an effective governance, regulation and stimulation of shareable data-applications in the health & life sciences. Yet, cutting edge medical innovation requires more than freely available big data and machine-generated data. Pushing the boundaries of biomedical research also demands smart data and high quality data that are created and nourished through human intervention and considerable investments in an highly competitive environment. Intellectual Property Rights (IPRs) and related rights come into play when data producers protect their investment in such data. While the need of recalibrating IPRs to fully support “big and smart data” advances is being intensely debated, there seems to be much confusion about the availability of IPRs and their legal effects. This presentation provides a very brief overview on selected areas that demonstrate emerging tensions at the interface of Big Data, Standardization, IPRs and Competition/Antitrust Law.",

author = "Timo Minssen",

year = "2018",

month = mar,

language = "English",

note = "BIOLAWLAPALOOZA 2018 ; Conference date: 22-03-2018 Through 23-03-2018",

url = "https://law.stanford.edu/center-for-law-and-the-biosciences/",

}

TY - ABST

T1 - FAIR DATA SHARING & DATA CARING IN THE DIGITALIZED ERA: ASPIRATIONS, REALITIES & LEGAL CLASHES IN THE HEALTH & LIFE SCIENCES

T2 - BIOLAWLAPALOOZA 2018

AU - Minssen, Timo

PY - 2018/3

Y1 - 2018/3

N2 - The huge prospects of Big Data, advanced machine learning and AI, as well as the shift to more “personalized”, “open” and “transparent” innovation models stress the importance of an effective governance, regulation and stimulation of shareable data-applications in the health & life sciences. Yet, cutting edge medical innovation requires more than freely available big data and machine-generated data. Pushing the boundaries of biomedical research also demands smart data and high quality data that are created and nourished through human intervention and considerable investments in an highly competitive environment. Intellectual Property Rights (IPRs) and related rights come into play when data producers protect their investment in such data. While the need of recalibrating IPRs to fully support “big and smart data” advances is being intensely debated, there seems to be much confusion about the availability of IPRs and their legal effects. This presentation provides a very brief overview on selected areas that demonstrate emerging tensions at the interface of Big Data, Standardization, IPRs and Competition/Antitrust Law.

AB - The huge prospects of Big Data, advanced machine learning and AI, as well as the shift to more “personalized”, “open” and “transparent” innovation models stress the importance of an effective governance, regulation and stimulation of shareable data-applications in the health & life sciences. Yet, cutting edge medical innovation requires more than freely available big data and machine-generated data. Pushing the boundaries of biomedical research also demands smart data and high quality data that are created and nourished through human intervention and considerable investments in an highly competitive environment. Intellectual Property Rights (IPRs) and related rights come into play when data producers protect their investment in such data. While the need of recalibrating IPRs to fully support “big and smart data” advances is being intensely debated, there seems to be much confusion about the availability of IPRs and their legal effects. This presentation provides a very brief overview on selected areas that demonstrate emerging tensions at the interface of Big Data, Standardization, IPRs and Competition/Antitrust Law.

M3 - Conference abstract for conference

Y2 - 22 March 2018 through 23 March 2018

ER -